Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae.

Barbee LA, Soge OO, Holmes KK, Golden MR.

J Antimicrob Chemother. 2014 Jun;69(6):1572-8. doi: 10.1093/jac/dkt540. Epub 2014 Jan 26.

PMID:
24468865
[PubMed - in process]
2.

Combination therapy for gonorrhoea: in vitro synergy testing.

Pereira R, Cole MJ, Ison CA.

J Antimicrob Chemother. 2013 Mar;68(3):640-3. doi: 10.1093/jac/dks449. Epub 2012 Nov 14.

PMID:
23152483
[PubMed - indexed for MEDLINE]
Free Article
3.

In vitro activities of antimicrobial combinations against clinical isolates of Neisseria gonorrhoeae.

Furuya R, Koga Y, Irie S, Ikeda F, Kanayama A, Kobayashi I, Tanaka M.

J Infect Chemother. 2013 Dec;19(6):1218-20. doi: 10.1007/s10156-013-0597-6. Epub 2013 Apr 8.

PMID:
23564350
[PubMed - in process]
4.

Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.

Starnino S; GASP-LAC Working Group, Galarza P, Carvallo ME, Benzaken AS, Ballesteros AM, Cruz OM, Hernandez AL, Carbajal JL, Borthagaray G, Payares D, Dillon JA.

Sex Transm Dis. 2012 Oct;39(10):813-21.

PMID:
23001269
[PubMed - indexed for MEDLINE]
6.

Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.

Kovari H, de Melo Oliveira MD, Hauser P, Läuchli S, Meyer J, Weber R, Zbinden R.

BMC Infect Dis. 2013 Dec 26;13:603. doi: 10.1186/1471-2334-13-603.

PMID:
24369054
[PubMed - in process]
Free PMC Article
7.

Comparison of E-test with agar dilution methods in testing susceptibility of N. gonorrhoeae to azithromycin.

Yasin RM, Suan KA, Meng CY.

Sex Transm Dis. 1997 May;24(5):257-60.

PMID:
9153733
[PubMed - indexed for MEDLINE]
8.

Assessment of Etest as an alternative to agar dilution for antimicrobial susceptibility testing of Neisseria gonorrhoeae.

Liu H, Taylor TH Jr, Pettus K, Trees D.

J Clin Microbiol. 2014 May;52(5):1435-40. doi: 10.1128/JCM.02131-13. Epub 2014 Feb 19.

PMID:
24554750
[PubMed - in process]
9.

Comparison of Neisseria gonorrhoeae MICs Obtained by Etest and Agar Dilution for Ceftriaxone, Cefpodoxime, Cefixime and Azithromycin.

Gose S, Kong CJ, Lee Y, Samuel MC, Bauer HM, Dixon P, Soge OO, Lei J, Pandori M.

J Microbiol Methods. 2013 Oct 24. pii: S0167-7012(13)00322-9. doi: 10.1016/j.mimet.2013.10.007. [Epub ahead of print]

PMID:
24513503
[PubMed - as supplied by publisher]
11.

In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.

Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.

Int J Antimicrob Agents. 2006 Mar;27(3):224-8. Epub 2006 Feb 7.

PMID:
16464562
[PubMed - indexed for MEDLINE]
12.

Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011.

Olsen B, Pham TL, Golparian D, Johansson E, Tran HK, Unemo M.

BMC Infect Dis. 2013 Jan 25;13:40. doi: 10.1186/1471-2334-13-40.

PMID:
23351067
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.

Mlynarczyk-Bonikowska B, Serwin AB, Golparian D, Walter de Walthoffen S, Majewski S, Koper M, Malejczyk M, Domeika M, Unemo M.

BMC Infect Dis. 2014 Feb 6;14:65. doi: 10.1186/1471-2334-14-65.

PMID:
24502606
[PubMed - in process]
Free PMC Article
14.

High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998.

Sosa J, Ramirez-Arcos S, Ruben M, Li H, Llanes R, Llop A, Dillon JA.

Sex Transm Dis. 2003 May;30(5):443-8.

PMID:
12916137
[PubMed - indexed for MEDLINE]
15.

Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.

Knapp JS, Wongba C, Limpakarnjanarat K, Young NL, Parekh MC, Neal SW, Buatiang A, Chitwarakorn A, Mastro TD.

Sex Transm Dis. 1997 Mar;24(3):142-8.

PMID:
9132980
[PubMed - indexed for MEDLINE]
16.

Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009.

Martin I, Jayaraman G, Wong T, Liu G, Gilmour M; Canadian Public Health Laboratory Network.

Sex Transm Dis. 2011 Oct;38(10):892-8. doi: 10.1097/OLQ.0b013e31822c664f.

PMID:
21934558
[PubMed - indexed for MEDLINE]
17.

Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.

Mbwana J, Mhalu F, Mwakagile D, Masesa J, Moshiro C, Sandstrom E.

East Afr Med J. 1999 Jun;76(6):330-4.

PMID:
10750520
[PubMed - indexed for MEDLINE]
18.
19.

In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae.

Furuya R, Nakayama H, Kanayama A, Saika T, Iyoda T, Tatewaki M, Matsuzaki K, Kobayashi I, Tanaka M.

J Infect Chemother. 2006 Aug;12(4):172-6.

PMID:
16944253
[PubMed - indexed for MEDLINE]
20.

Antimicrobial susceptibility of Neisseria gonorrhoeae isolates determined by the agar dilution, disk diffusion and Etest methods: comparison of results using GC agar and chocolate agar.

Liao CH, Lai CC, Hsu MS, Chu FY, Wu MY, Huang YT, Hsueh PR.

Int J Antimicrob Agents. 2010 May;35(5):457-60. doi: 10.1016/j.ijantimicag.2010.01.007. Epub 2010 Feb 25.

PMID:
20188518
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk